SCOPE 2024 To Feature First-Ever Start Up Pitch Competition
By Clinical Research News Staff
November 28, 2023 | The first-ever Clinical Trial Tech: Start Up Pitch Contest will be held on Feb. 12, 2024, in conjunction with the annual Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida. Emerging clinical trial companies with less than $10 million in funding and a groundbreaking product are invited to apply for further investment by Dec. 15.
Six high-potential companies will be pre-selected to make their pitch to a panel of judges—and an exclusive audience of senior-level investors from Bessemer Ventures Partners and McKesson Ventures, corporate executives from Merk Global Health Innovation Fund and Eli Lily, and industry leaders from Amazon Web Services and dRx Capital (Novartis) in the space of five to seven minutes. This will be followed by a question-and-answer session conducted by the judges, for a total of 10 minutes.
The six finalists will be awarded a complimentary registration to attend SCOPE 2024 taking place Feb. 11-14. The winning startup will be announced live at the Clinical Trial Tech: Venture, Innovation, & Partnering Conference as well as across the broader SCOPE program.
Selected participants will gain the chance to present their pioneering solutions to a gathering of investors eager to back the transformative advancements of clinical trial startups. The boutique event is designed to be an opportunity for a company in the first stages of operation to gain strategic insights, honest perspectives, and practical business recommendations for collaboration and investment from industry experts.
Submissions should include a written company overview and links to informational/pitch decks, all within a 250-word limit. Applicants are also asked to provide concise descriptions (150 words or less) of their product's unique features, achievements to date, competitive advantages, market landscape, key benchmarks, and remaining challenges.
Contest judges will be Andrew Hedin, a partner in Bessemer Venture Partners; Dan Hydes, chief executive officer and cofounder of IgniteData; and Ward Lemaire, head of data management at Johnson & Jonson Innovative Medicine.